Analysis of risk factors and prognostic prediction in advanced colorectal cancer undergoing immunotherapy combined with targeted therapy
This study highlights the prognostic significance of both clinical and inflammatory markers in pMMR advanced colorectal cancer undergoing immunotherapy combined with targeted therapy. The developed nomogram facilitates individualized survival prediction, offering clinicians a practical tool to tailor treatment and follow-up strategies for improved patient management.
Authors
- Ya‐Fang Chen (ORCID: https://orcid.org/0000-0003-2995-9189)
- Ying Hu (ORCID: https://orcid.org/0000-0003-0301-7273)
- Xiaomei Liu (ORCID: https://orcid.org/0009-0006-2616-4988)
- Xiaotian Dai (ORCID: https://orcid.org/0009-0003-1959-1402)
- Shuang Hao (ORCID: https://orcid.org/0000-0002-2479-5819)
- Yuan Yuan (ORCID: https://orcid.org/0009-0002-9540-2100)
Institutions
- Army Medical University (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-10-15
- DOI
- https://doi.org/10.3389/fmed.2025.1640469
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05